Cutaneous anthrax: a concise review.
With the growing threat of bioterrorism, it has become important for clinicians to recognize the clinical manifestations of diseases spread in this manner. The aim of this article is to provide readers with a complete and detailed understanding of anthrax, with a specific concentration on the cutaneous manifestations and a concentrated review of the treatment and current information known about Bacillus anthracis.
Tutrone
William D
WD
Department of Dermatology, St. Luke's-Roosevelt Medical Center, New York, New York 10025, USA.
Scheinfeld
Noah S
NS
Weinberg
Jeffrey M
JM
D000284:Administration, Oral; D000881:Anthrax / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage; D002939:Ciprofloxacin / Q000008:administration & dosage; D004318:Doxycycline / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006801:Humans; D007262:Infusions, Intravenous; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D004318:Doxycycline